摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-乙炔基-3,5-二甲基-1,2-恶唑 | 668970-91-0

中文名称
4-乙炔基-3,5-二甲基-1,2-恶唑
中文别名
——
英文名称
4-ethynyl-3,5-dimethylisoxazole
英文别名
4-ethynyl-3,5-dimethyl-1,2-oxazole
4-乙炔基-3,5-二甲基-1,2-恶唑化学式
CAS
668970-91-0
化学式
C7H7NO
mdl
MFCD08703589
分子量
121.139
InChiKey
VRIFFHHNSRUZNX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.285
  • 拓扑面积:
    26
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:0aace5d83300a4756faa76a6514db28e
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-乙炔基-3,5-二甲基-1,2-恶唑 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide1,8-二氮杂双环[5.4.0]十一碳-7-烯三乙胺 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 5.58h, 生成 tert-butyl 6-bromo-2-(3,5-dimethylisoxazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate
    参考文献:
    名称:
    Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)
    摘要:
    The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly over-expressed in many human cancers. MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy. PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncology. We report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo[3,2-c]pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to 65 (CCT251455). This potent and selective chemical tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compound to elucidate further the therapeutic potential of MPS1 inhibition.
    DOI:
    10.1021/jm401395s
  • 作为产物:
    描述:
    3,5-二甲基异唑copper(l) iodide 、 ammonium cerium (IV) nitrate 、 四丁基氟化铵 、 palladium diacetate 、 二异丙胺三苯基膦 作用下, 以 四氢呋喃N,N-二甲基甲酰胺乙腈 为溶剂, 反应 21.17h, 生成 4-乙炔基-3,5-二甲基-1,2-恶唑
    参考文献:
    名称:
    Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)
    摘要:
    The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly over-expressed in many human cancers. MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy. PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncology. We report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo[3,2-c]pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to 65 (CCT251455). This potent and selective chemical tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compound to elucidate further the therapeutic potential of MPS1 inhibition.
    DOI:
    10.1021/jm401395s
点击查看最新优质反应信息

文献信息

  • [EN] ANTIBACTERIAL BENZOIC ACID DERIVATIVES<br/>[FR] DERIVES D'ACIDES BENZOIQUES ANTIBACTERIENS
    申请人:UPJOHN CO
    公开号:WO2004018428A1
    公开(公告)日:2004-03-04
    The invention provides antimicrobial agents and methods of using the agents for sterilization, sanitation, antisepsis, disinfection, and treatment of infections in mammals.
    这项发明提供了抗菌剂和使用这些剂进行哺乳动物的消毒、卫生、防腐、消毒和治疗感染的方法。
  • 7-AZAINDOLE INHIBITORS OF CRAC
    申请人:Hoffmann-La Roche Inc.
    公开号:US20130158049A1
    公开(公告)日:2013-06-20
    Disclosed are compounds of Formula (I): useful for treatment of autoimmune and inflammatory diseases associated with IL-2 inhibition via modulation of calcium release-activated calcium (CRAC) channels. Also disclosed are methods of making and using the compounds for treatment of diseases associated with CRAC channels.
    公开了公式(I)的化合物: 用于治疗与IL-2抑制有关的自身免疫和炎症性疾病,通过调节钙释放激活钙(CRAC)通道。还公开了制造和使用这些化合物用于治疗与CRAC通道相关的疾病的方法。
  • [EN] GOLD (I)-PHOSPHINE 1,2,3-TRIAZOLE DERIVATIVES WITH ANTIOBIOTIC PROPERTIES<br/>[FR] DÉRIVÉS D'OR (I)-PHOSPHINE 1,2,3-TRIAZOLE PRÉSENTANT DES PROPRIÉTÉS ANTIBIOTIQUES
    申请人:UNIV STRASBOURG
    公开号:WO2019243273A1
    公开(公告)日:2019-12-26
    The present invention relates to gold (l)-phosphine 1,2,3-triazole compounds, and their use in a human or animal medicine. The present invention also relates to using such compounds for the prevention and/or treatment of an infection, i.e. inhibitors of growth of Gram-positive and/or Gram-negative bacteria. On another aspect the invention relates to the synthesis of the gold (l)-phosphine compounds of the invention and to their synthesis intermediates. The present invention finds applications in the medical, veterinary and/or chemical fields.
    本发明涉及金(l)-膦1,2,3-三唑化合物及其在人类或动物药物中的应用。本发明还涉及使用这类化合物预防和/或治疗感染,即抑制革兰氏阳性和/或革兰氏阴性细菌的生长。另一方面,本发明涉及合成本发明的金(l)-膦化合物及其合成中间体。本发明在医学、兽医和/或化学领域中找到应用。
  • Deconstructive Reorganization: De Novo Synthesis of Hydroxylated Benzofuran
    作者:Ling Zhang、Tongxiang Cao、Huanfeng Jiang、Shifa Zhu
    DOI:10.1002/anie.201915212
    日期:2020.3.16
    An unprecedented deconstructive reorganization strategy for the de novo synthesis of hydroxylated benzofurans from kojic acid- or maltol-derived alkynes is reported. In this reaction, both the benzene and furan rings were simultaneously constructed, whereas the pyrone moiety of the kojic acid or maltol was deconstructed and then reorganized into the benzene ring as a six-carbon component. Through this
    报道了一种空前的解构重组策略,用于从曲酸或麦芽酚衍生的炔烃从头合成羟基化苯并呋喃。在该反应中,同时构造了苯环和呋喃环,而曲酸或麦芽酚的吡喃酮部分被解构,然后以六碳组分重组为苯环。通过这种策略,以取代模式可调节的方式将至少一个游离羟基引入苯环,而无需进行保护-脱保护和氧化还原调节。通过这种方法,已经有效地制备了具有不同取代模式的大量羟基化苯并呋喃衍生物。
  • Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
    作者:A. Keeley、P. Ábrányi-Balogh、G. M. Keserű
    DOI:10.1039/c8md00327k
    日期:——

    A fragment library of electrophilic small heterocycles was characterized through cysteine-reactivity and aqueous stability tests that suggested their potential as covalent warheads.

    通过半胱氨酸反应性和水稳定性测试,对亲电性小杂环片段库进行了表征,结果表明它们有潜力作为共价战斗头。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺